Whitehawk Therapeutics, Inc. financial data

Symbol
WHWK on Nasdaq
Location
Morristown, NJ
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 06 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.33K % +182%
Quick Ratio 11.1 % -61%
Debt-to-equity 8.07 % -68.3%
Return On Equity -10.4 % +85.6%
Return On Assets -9.58 % +83.3%
Operating Margin -754 % -185%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 47.1M shares +91.2%
Common Stock, Shares, Outstanding 47.1M shares +91.5%
Common Stock, Value, Issued 4K USD +100%
Weighted Average Number of Shares Outstanding, Basic 69.2M shares +156%
Weighted Average Number of Shares Outstanding, Diluted 69.2M shares +156%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 14.4M USD -42.6%
Research and Development Expense 86.3M USD +74.5%
Costs and Expenses 123M USD +34.6%
Operating Income (Loss) -108M USD -63.8%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -15.6M USD +74.7%
Earnings Per Share, Basic 0 USD/shares +43.5%
Earnings Per Share, Diluted 0 USD/shares +43.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 37.9M USD +24.2%
Cash, Cash Equivalents, and Short-term Investments 163M USD +160%
Accounts Receivable, after Allowance for Credit Loss, Current 0 USD -100%
Inventory, Net 0 USD -100%
Assets, Current 165M USD +113%
Property, Plant and Equipment, Net 4K USD -99.9%
Operating Lease, Right-of-Use Asset 0 USD -100%
Other Assets, Noncurrent 1.98M USD +30.5%
Assets 167M USD +94.9%
Accounts Payable, Current 1.63M USD +18.9%
Accrued Liabilities, Current 8.22K USD
Liabilities, Current 9.85M USD -37.7%
Operating Lease, Liability, Noncurrent 0 USD -100%
Other Liabilities, Noncurrent 0 USD -100%
Liabilities 9.85M USD -41.5%
Accumulated Other Comprehensive Income (Loss), Net of Tax 139K USD +256%
Retained Earnings (Accumulated Deficit) -330M USD -4.97%
Stockholders' Equity Attributable to Parent 157M USD +128%
Liabilities and Equity 167M USD +94.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -11.9M USD +39.6%
Net Cash Provided by (Used in) Investing Activities 115M USD +994%
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 47.1M shares +91.5%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 199M USD
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD -100%
Deferred Tax Assets, Valuation Allowance 122M USD +69%
Operating Lease, Liability 0 USD -100%
Depreciation 132K USD -40.5%
Payments to Acquire Property, Plant, and Equipment 551K USD -25.4%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -15.5M USD +74.8%
Lessee, Operating Lease, Liability, to be Paid 940K USD -35.3%
Property, Plant and Equipment, Gross 377K USD -94.1%
Operating Lease, Liability, Current 0 USD -100%
Lessee, Operating Lease, Liability, to be Paid, Year Two 231K USD -27.8%
Lessee, Operating Lease, Liability, to be Paid, Year One 320K USD -37.5%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 107K USD -42.2%
Lessee, Operating Lease, Liability, to be Paid, Year Three 280K USD +21.2%
Deferred Tax Assets, Operating Loss Carryforwards 49.2M USD +12.6%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 5.37M USD +16.8%
Lessee, Operating Lease, Liability, to be Paid, Year Four 109K USD -61.1%
Operating Lease, Payments 99K USD -21.4%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 390K USD -30.4%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%